Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures
- PMID: 20587679
- DOI: 10.1542/peds.2010-0665
Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures
Abstract
Objective: In February 2008, we alerted the Advisory Committee on Immunization Practices to preliminary evidence of a twofold increased risk of febrile seizures after the combination measles-mumps-rubella-varicella (MMRV) vaccine when compared with separate measles-mumps-rubella (MMR) and varicella vaccines. Now with data on twice as many vaccine recipients, our goal was to reexamine seizure risk after MMRV vaccine.
Methods: Using 2000-2008 Vaccine Safety Datalink data, we assessed seizures and fever visits among children aged 12 to 23 months after MMRV and separate MMR + varicella vaccines. We compared seizure risk after MMRV vaccine to that after MMR + varicella vaccines by using Poisson regression as well as with supplementary regressions that incorporated chart-review results and self-controlled analyses.
Results: MMRV vaccine recipients (83,107) were compared with recipients of MMR + varicella vaccines (376,354). Seizure and fever significantly clustered 7 to 10 days after vaccination with all measles-containing vaccines but not after varicella vaccination alone. Seizure risk during days 7 to 10 was higher after MMRV than after MMR + varicella vaccination (relative risk: 1.98 [95% confidence interval: 1.43-2.73]). Supplementary analyses yielded similar results. The excess risk for febrile seizures 7 to 10 days after MMRV compared with separate MMR + varicella vaccination was 4.3 per 10,000 doses (95% confidence interval: 2.6-5.6).
Conclusions: Among 12- to 23-month-olds who received their first dose of measles-containing vaccine, fever and seizure were elevated 7 to 10 days after vaccination. Vaccination with MMRV results in 1 additional febrile seizure for every 2300 doses given instead of separate MMR + varicella vaccines. Providers who recommend MMRV should communicate to parents that it increases the risk of fever and seizure over that already associated with measles-containing vaccines.
Comment in
-
Measles-mumps-rubella-varicella combination vaccine increases risk of febrile seizure.J Pediatr. 2011 Jan;158(1):170. doi: 10.1016/j.jpeds.2010.09.075. J Pediatr. 2011. PMID: 21146049 No abstract available.
Similar articles
-
Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad context.Expert Rev Vaccines. 2023 Jan-Dec;22(1):764-776. doi: 10.1080/14760584.2023.2252065. Expert Rev Vaccines. 2023. PMID: 37642012 Review.
-
Febrile seizures and measles-mumps-rubella-varicella (MMRV) vaccine: what do primary care physicians think?Vaccine. 2012 Nov 6;30(48):6731-3. doi: 10.1016/j.vaccine.2012.08.075. Epub 2012 Sep 10. Vaccine. 2012. PMID: 22975026
-
Policy statement—Prevention of varicella: update of recommendations for use of quadrivalent and monovalent varicella vaccines in children.Pediatrics. 2011 Sep;128(3):630-2. doi: 10.1542/peds.2011-1968. Epub 2011 Aug 28. Pediatrics. 2011. PMID: 21873692
-
Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2010 May 7;59(RR-3):1-12. MMWR Recomm Rep. 2010. PMID: 20448530
-
Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine.MMWR Morb Mortal Wkly Rep. 2008 Mar 14;57(10):258-60. MMWR Morb Mortal Wkly Rep. 2008. PMID: 18340332
Cited by
-
Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data.Am J Epidemiol. 2023 Feb 1;192(2):205-216. doi: 10.1093/aje/kwac170. Am J Epidemiol. 2023. PMID: 36193854 Free PMC article.
-
Current Approaches to Vaccine Safety Using Observational Data: A Rationale for the EUMAEUS (Evaluating Use of Methods for Adverse Events Under Surveillance-for Vaccines) Study Design.Front Pharmacol. 2022 Mar 22;13:837632. doi: 10.3389/fphar.2022.837632. eCollection 2022. Front Pharmacol. 2022. PMID: 35392566 Free PMC article. Review.
-
Safety of measles and pertussis-containing vaccines in children with autism spectrum disorders.Vaccine. 2022 Apr 20;40(18):2568-2573. doi: 10.1016/j.vaccine.2022.03.031. Epub 2022 Mar 18. Vaccine. 2022. PMID: 35315325 Free PMC article.
-
The Cosmos Collaborative: A Vendor-Facilitated Electronic Health Record Data Aggregation Platform.ACI open. 2021 Jan;5(1):e36-e46. doi: 10.1055/s-0041-1731004. ACI open. 2021. PMID: 35071993 Free PMC article.
-
Using Population-Based Structures to Actively Monitor AEFIs during a Mass Immunization Campaign-A Case of Measles-Rubella and Polio Vaccines.Vaccines (Basel). 2021 Nov 8;9(11):1293. doi: 10.3390/vaccines9111293. Vaccines (Basel). 2021. PMID: 34835224 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical